Romina A. Danguilan

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1

Anantharaman Vathsala, E.T. Ona, S P Tan et al. · Transplantation · 2005 · 109 citations

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text

Cytomegalovirus Disease in Kidney Transplant Recipients: Incidence, Clinical Profile, and Risk Factors

Elisa Cordero, Concesa Casasola, R. Ecarma et al. · Transplantation Proceedings · 2012 · 73 citations

Transplantation, Kidney Transplant, Kidney Transplantation +7

Rituximab in Highly Sensitized Kidney Transplant Recipients

Angélica Muñoz, A.A. Rioveros, Concesa B. Cabanayan-Casasola et al. · Transplantation Proceedings · 2008 · 27 citations

Urology, Transplantation, Kidney Transplant +4